Patents for C40B 30 - Methods of screening libraries (11,320)
06/2011
06/30/2011US20110160188 Paramyxovirus family inhibitors and methods of use thereof
06/30/2011US20110160087 Method for increasing efficiency of germplasm screening in plant transformation
06/30/2011US20110160086 Gene expression signature for classification of kidney tumors
06/30/2011US20110160085 Biomarkers for anti-tnf treatment in ulcreative colitis and related disorders
06/30/2011US20110160084 Protein Chips for HPV Detection
06/30/2011US20110160083 High spatial resolution imaging of a structure of interest in a specimen
06/30/2011US20110160082 Mobility-Modified Nucleobase Polymers and Methods of Using Same
06/30/2011US20110160081 functional complementation assay for defined gpcr oligomers
06/30/2011US20110160080 Diagnosis of Melanoma and Solar Lentigo by Nucleic Acid Analysis
06/30/2011US20110160079 Tool for diagnosis and prognosis of mature b-cell neoplasms
06/30/2011US20110160078 Digital Counting of Individual Molecules by Stochastic Attachment of Diverse Labels
06/30/2011US20110160077 Sequencing methods using enzyme conformation
06/30/2011US20110160076 Methods for producing uniquely specific nucleic acid probes
06/30/2011US20110160075 Diagnostic assay for orientia tsutsugamushi by detection of responsive gene expression
06/30/2011US20110160074 Capture Ligand Controls, Blocking Probes, Masking Probes and Methods of Using the Same
06/30/2011US20110160073 Systems and methods for fluorescence detection with a movable detection module
06/30/2011US20110160072 Method of diagnosing neoplasms
06/30/2011US20110160071 Novel Proteins and Methods for Designing the Same
06/30/2011US20110160070 Copd biomarker signatures
06/30/2011US20110160069 Analyte detection using a needle projection patch
06/30/2011US20110160068 Automated seed sampling apparatus, method and system
06/30/2011US20110160067 High throughput system for isolation, growth, and detection of lipid inclusions in bacteria
06/30/2011US20110159500 Compositions including ginger for the amelioration or prevention of inflammatory conditions
06/30/2011US20110158997 Single chain fragment variable antibody libraries and uses thereof
06/30/2011US20110158979 Genetic component of complications in type 2 diabetes
06/30/2011US20110158953 Tumor suppression through plexin c1
06/30/2011US20110156701 Rotating magnetic field for improved detection in cluster assays
06/30/2011CA2785359A1 Protein display
06/29/2011EP2339350A1 Arrays
06/29/2011EP2337861A1 Methods for classifying samples based on network modularity
06/28/2011CA2479999C Method and kit for detecting membrane protein-protein interactions
06/23/2011WO2011073536A1 Platform system, elements and use thereof, and manufacturing methods
06/23/2011WO2011072487A1 Crystal of recombinant interferon with altered spatial configuration, three-dimensional structure and uses thereof
06/23/2011US20110152500 Bipodal-Peptide Binder
06/23/2011US20110152357 Micro-RNA-Based Compositions and Methods for the Diagnosis, Prognosis and Treatment of Multiple Myeloma
06/23/2011US20110152340 Methods for Identifying Subjects With an Increased Likelihood of Responding to DPP-IV Inhibitors
06/23/2011US20110152166 Method of modulation of protein phosphorylation-dependent conformational transitions with low molecular weight compounds
06/23/2011US20110152124 Electrical and reusable device for reading microarrays
06/23/2011US20110152123 Cellular screening substratum and manufacturing process for it, and method and apparatus for cellular screening with it
06/23/2011US20110152122 Compositions and Methods for the Identification and Use of Epigenetic Markers Useful in the Study of Normal and Abnormal Mammalian Gametogenesis
06/23/2011US20110152121 Apparatus and method for multiple immunoassays on a chip
06/23/2011US20110152120 method of characterizing antibodies
06/23/2011US20110152119 Quantification Method of Biochemical Substances Using Ion Scattering Spectroscopy and Specific-Binding Efficiency Quantification Method of Biochemical Substances Using Ion Scattering Spectroscopy
06/23/2011US20110152118 Method and system for determination of molecular interaction parameters
06/23/2011US20110152117 Methods of determining efficacy of treatments of diseases of the bowel
06/23/2011US20110152116 Nanoassays
06/23/2011US20110152115 Methods for identifying, diagnosing, and predicting survival of lymphomas
06/23/2011US20110152114 Short cycle methods for sequencing polynucleotides
06/23/2011US20110152113 Genomic fingerprint of breast cancer
06/23/2011US20110152112 Diagnosis and treatment of reverse cholesterol transport deficiency-related diseases
06/23/2011US20110152111 Multiplex nucleic acid analysis using archived or fixed samples
06/23/2011US20110152110 Set of Tumour-Markers
06/23/2011US20110152109 Biological sample target classification, detection and selection methods, and related arrays and oligonucleotide probes
06/23/2011US20110152108 Devices and Methods for Thermally-Mediated Chemical Reactions
06/23/2011US20110152107 Drug Screening Via Nanpore Silicon Filters
06/23/2011US20110152106 Cst1, dcc1, ifitm1 or melk as markers for diagnosing stomach cancer
06/23/2011US20110150775 Genomic approaches to fetal treatment and diagnosis
06/23/2011CA2784624A1 Crystal of recombinant interferon with altered spatial configuration, three-dimensional structure and uses thereof
06/22/2011EP2334692A1 Rna monomers containing o-acetal levulinyl ester groups and their use in rna microarrays
06/22/2011EP1360207B1 Protein arrays of camelid heavy-chain immunoglobulin variable domains
06/21/2011US7964534 Nuclear magnetic resonance assembly of chemical entities using advanced antenna probes
06/21/2011CA2497740C Multiplexed analysis of polymorphic loci by probe elongation-mediated detection
06/16/2011WO2011047146A3 Methods of affinity maturing antibodies
06/16/2011WO2011008262A9 Methods and apparatus for diagnosis and/or prognosis of cancer
06/16/2011US20110144206 Use of a cox-2 inhibitor for the treatment of a cox-2 dependent disorder in a patient not carrying hla alleles associated with hepatotoxicity
06/16/2011US20110144076 Preterm delivery diagnostic assay
06/16/2011US20110143998 Identification and use of peptide inhibitors of protein synthesis
06/16/2011US20110143960 3d-models for high-throughput screening drug discovery and development
06/16/2011US20110143959 Compositions and methods for determining the prognosis of bladder urothelial cancer
06/16/2011US20110143958 Methods of Identifying Modulators of Ubiquitin Ligases
06/16/2011US20110143957 Subtractive single label comparative hybridization
06/16/2011US20110143956 Diagnostic Kits and Methods for SCD or SCA Therapy Selection
06/16/2011US20110143955 Protein Capture, Detection and Quantitation
06/16/2011US20110143954 Gamma-secretase substrate and methods of use
06/16/2011US20110143953 Synthetic Antibodies
06/16/2011US20110143952 Chromatographic device and method of fabrication and chromatographic methods
06/16/2011US20110143951 Mass markers and methods
06/16/2011US20110143950 Diagnosis/Treatment Option for Head-and-Neck Tumor Using Micro-RNA as Biomarker
06/16/2011US20110143949 Analysis using microfluidic partitioning devices
06/16/2011US20110143948 Molecular signatures and biomarkers associated with melanoma and methods of use thereof
06/16/2011US20110143947 Assay Apparatuses, Consumables and Methods
06/16/2011US20110143946 Method for predicting the response of a tumor in a patient suffering from or at risk of developing recurrent gynecologic cancer towards a chemotherapeutic agent
06/16/2011US20110142830 Modulation of the trpv: vps10p receptor system for the treatment of pain
06/16/2011US20110142828 Treatment prediction involving hmgcr
06/16/2011US20110142822 Crystal of egfr extracellular domain and cetuximab fab fragment, and uses thereof
06/16/2011US20110142799 Modulation of neurodegenerative disease by modulating xbp-1 activity
06/16/2011DE102010027827B3 Verfahren und Mittel zur Identifizierung von Substanzen, welche die IgE-Produktion hemmen Method and means for identifying substances that inhibit the IgE production
06/16/2011CA2807050A1 Diagnostic biomarker to identify women at risk for preterm delivery
06/15/2011EP2332645A1 Apparatus for chemical and biochemical reactions using photo-generated reagents
06/15/2011EP1597585B1 Method for selecting a candidate drug compound
06/15/2011CN101168781B In vitro activity measuring method for hepatitis C virus RNA depending RNA polymerase and application thereof
06/14/2011CA2785999A1 Mean dna copy number of chromosomal regions is of prognostic significance in cancer
06/14/2011CA2478203C Encoded self-assembling chemical libraries (esachel)
06/09/2011WO2011068798A1 Methods of modulating thrombocytopenia and modified transgenic pigs
06/09/2011WO2011068518A1 Multiplexed quantitative pcr end point analysis of nucleic acid targets
06/09/2011WO2011066660A1 Lsc and hsc signatures for predicting survival of patients having hematological cancer
06/09/2011WO2011066655A1 Combined on-lattice/off-lattice optimization method for rigid body docking
06/09/2011US20110136738 Alternatively Transcribed Genes Associated with Schizophrenia
06/09/2011US20110136727 Compositions and methods for rapid selection of pathogen binding agents
06/09/2011US20110136692 Protein microarrays for mass spectrometry and methods of use therefor
1 ... 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 ... 114